Gerard Michael — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
Gerard Michael is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market purchases: $15K.
Profile
Michael Gerard is listed as General Counsel of Cabaletta Bio, Inc. in SEC filings with CIK 0001881529, the most recent filing dated 2026-01-21. Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune diseases, notably CAART cells designed to target pathogenic B cells; Gerard's role centers on corporate governance, regulatory compliance, and legal affairs for the company.
Role
Insider
Notability
40/100
Board memberships
Cabaletta Bio, Inc.
Awards & honors
Serves as General Counsel for Cabaletta Bio, guiding legal strategy and governance during public filings.
Oversees regulatory compliance and corporate documentation for a clinical-stage biotech with CAART technology.
Supports strategic initiatives and intellectual property management in biotech oncology/autimmune programs.
Michael Gerard is listed as General Counsel of Cabaletta Bio, Inc. in SEC filings with CIK 0001881529, the most recent filing dated 2026-01-21. Cabaletta Bio is a clinical-stage biotechnology company developing engineered T cell therapies for autoimmune diseases, notably CAART cells designed to target pathogenic B cells; Gerard's role centers on corporate governance, regulatory…
Has Gerard Michael been buying or selling stock?
Recorded transactions: 1 open-market purchases ($15K) and 0 open-market sales () across all tracked filings.
Where can I see all of Gerard Michael's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
